Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-15

FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves a generic pyridostigmine bromide product under an Original Application (ANDA205464). The indication is treatment of myasthenia gravis, with Rising …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

ORIG AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)